Abstract
Patients with severe SARS-CoV-2 infection require significant hospital resources. However, since the disease was first identified, treatments have evolved rapidly, reducing fatality rates. This study was designed to evaluate changes in healthcare utilization and cost in patients with in-hospital mortality, from earliest time of disease identification to May 2020.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
